The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Cancer mortality in patients with schizophrenia: An 11‐year prospective cohort study
Abstract
BACKGROUND: Schizophrenia has been associated with a rate of premature mortality that is 2 to 3 times higher than that in the general population. Although the role of cancer in this excess mortality remains unclear, previous incidence or mortality studies found contradictory results. METHODS: In 1993, a large prospective study was initiated in a cohort of 3470 patients with schizophrenia to examine cancer‐related mortality and predictors. Standardized mortality ratios (SMRs) were calculated, adjusting for age and sex relative to a representative sample of the French general population. RESULTS: During the 11‐year follow‐up, 476 (14%) patients died; the mortality rate was thus nearly 4‐fold higher than in the general population. Cancer was the second most frequent cause of mortality (n = 74), with a global SMR of 1.5 (95% confidence interval [95% CI], 1.2‐1.9). For all cancers, the SMRs were 1.4 (not significant) for men and 1.9 (95% CI, 1.4‐2.8) for women. For men, lung cancer was the most frequent localization (n = 23; 50%), with an SMR of 2.2 (95% CI, 1.6‐3.3). For women, breast cancer was the most frequent localization (n = 11; 39%), with an SMR of 2.8 (95% CI, 1.6‐4.9). In comparison with patients who did not die of cancer, there were 2 significant baseline predictors of death by lung cancer in the final logistic regression model: duration of smoking and age >38 years. CONCLUSIONS: The results of the current study demonstrated an increased risk of mortality by cancer in patients with schizophrenia, especially for women from breast cancer and for men from lung cancer. Cancer 2009. © 2009 American Cancer Society.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, other studies found an increased (9,21,28,(449)(450)(451) or no different (292,419,452,453) overall risk of cancer in patients with schizophrenia compared to the general population.”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [21]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
International Classification of Diseases
Jones, F. A. (1978) · Gut · doi:10.1136/gut.19.12.1175 · Cited by 2,919
The CAGE Questionnaire: Validation of a New Alcoholism Screening Instrument
Mayfield, D. G., McLeod, G. A., & Hall, P. B. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.10.1121 · Cited by 2,261
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology
TANDON, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.011 · Cited by 770
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679
Research works printed but not linked: 2
- World Health Organization, 1994, The ICD‐10 classification of mental and behavioural disorders: diagnostic criteria for research
- Catts VS, 2007, No in vitro anti‐cancer effect of antipsychotic drugs at doses used in the psychiatric clinic, Schizophr Bull., 33, 230
Cited by
Sorted by citations
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Premature Mortality Among Adults With Schizophrenia in the United States
Olfson, M., Gerhard, T., Huang, C., Crystal, S., & Stroup, T. S. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1737 · Cited by 1,083
Correll, C. U., Solmi, M., Croatto, G., Schneider, L. K., Rohani-Montez, S. C., Fairley, L., Smith, N., Bitter, I., Gorwood, P. A. P. M., Taipale, H. T., et al. (2022) · World Psychiatry · doi:10.1002/wps.20994 · Cited by 758
Barnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 615
Barnes, T. R. E. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 369
Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00137 · Cited by 365
The epidemiology of excess mortality in people with mental illness
Lawrence, D., Kisely, S., & Pais, J. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005501202 · Cited by 258
Callaghan, R. C., Veldhuizen, S., Jeysingh, T., Orlan, C., Graham, C., Kakouris, G., Remington, G., & Gatley, J. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.09.014 · Cited by 255
Cancer care for individuals with schizophrenia
Irwin, K. E., Henderson, D. C., Knight, H. P., & Pirl, W. F. (2013) · Cancer · doi:10.1002/cncr.28431 · Cited by 191
Review: Mortality in schizophrenia: a measurable clinical endpoint
Bushe, C. J., Taylor, M., & Haukka, J. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382468 · Cited by 185
Cancer diagnosis in people with severe mental illness: practical and ethical issues
Howard, L. M., Barley, E. A., Davies, E., Rigg, A. S., Lempp, H. K., Rose, D. S., Taylor, D. M., & Thornicroft, G. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70085-1 · Cited by 182
Oakley, P., Kisely, S. R., Baxter, A. J., Harris, M., Desoe, J., Dziouba, A., & Siskind, D. J. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.019 · Cited by 152
Smokers With Behavioral Health Comorbidity Should Be Designated a Tobacco Use Disparity Group
Williams, J. M., Steinberg, M. L., Griffiths, K. G., & Cooperman, N. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301232 · Cited by 135
Dying Too Soon: Excess Mortality in Severe Mental Illness
de Mooij, L. D., Kikkert, M., Theunissen, J., Beekman, A. T. F., de Haan, L., Duurkoop, P. W. R. A., Van, H. L., & Dekker, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00855 · Cited by 132
Drug Repositioning in Glioblastoma: A Pathway Perspective
Tan, S. K., Jermakowicz, A. M., Mookhtiar, A. K., Nemeroff, C. B., Schürer, S. C., & Ayad, N. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00218 · Cited by 116
Cancer screening, prevention, and treatment in people with mental illness
Weinstein, L. C., Stefančić, A., Cunningham, A., Hurley, K. E., Cabassa, L. J., & Wender, R. C. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21334 · Cited by 112
Causes of mortality in schizophrenia: an updated review of European studies
Department of Psychiatry, W. M. U., Piotrowski, P., M. Gondek, T., Department of Psychiatry, W. M. U., Królicka-Deręgowska, A., Department of Psychiatry, W. M. U., Misiak, B., Department of Genetics, W. M. U., Adamowski, T., Department of Nervous System Diseases, F. O. H. S., et al. (2017) · Psychiatria Danubina · doi:10.24869/psyd.2017.108 · Cited by 107
“In general, mortality in schizophrenia is increased versus a reference population, where increase in mortality from individual causes of death is unambiguous (Allebeck 1989, Mortensen & Juel 1993, Brown 1997, Saha et al. 2007, Tran et al. 2009).”
BackgroundHert, M. A. F. D., Peuskens, J., Sabbe, T., Mitchell, A. J., Stubbs, B., Neven, P., Wildiers, H. P. M. W., & Detraux, J. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12459 · Cited by 99
γ-H2AX and other histone post-translational modifications in the clinic
Redon, C. E., Weyemi, U., Parekh, P. R., Huang, D., Burrell, A. S., & Bonner, W. M. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.02.021 · Cited by 97
Mitchell, A. J., Vancampfort, D., Binder, M. D., & Stubbs, B. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.11.006 · Cited by 101
Review: Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?
Wildgust, H. J., & Beary, M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810384639 · Cited by 97
Cancer mortality in patients with schizophrenia: systematic review and meta-analysis
Zhuo, C., Tao, R., Jiang, R., Lin, X., & Shao, M. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.195776 · Cited by 93
Bridge: Person-Centered Collaborative Care for Patients with Serious Mental Illness and Cancer
Irwin, K. E., Park, E. R., Fields, L. E., Corveleyn, A. E., Greer, J. A., Perez, G. K., Callaway, C. A., Jacobs, J. M., Nierenberg, A. A., Temel, J. S., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0488 · Cited by 92
Iglay, K., Santorelli, M. L., Hirshfield, K. M., Williams, J. M., Rhoads, G. G., Lin, Y., & Demissie, K. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.4947 · Cited by 89
Fond, G. B., Salas, S., Pauly, V., Baumstarck, K., Bernard, C., Orléans, V., Llorca, P., Lançon, C., Auquier, P., & Boyer, L. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30187-2 · Cited by 89
Cardiovascular aspects of antipsychotics
Raedler, T. J. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833f46c9 · Cited by 89
Review: Cancer and schizophrenia: is there a paradox?
Hodgson, R. E., Wildgust, H. J., & Bushe, C. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385489 · Cited by 86
Beary, M., Hodgson, R., & Wildgust, H. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112440512 · Cited by 79
The paradox of premature mortality in schizophrenia: new research questions
Wildgust, H. J., Hodgson, R. E., & Beary, M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382149 · Cited by 78
Cardiovascular diseases among patients with schizophrenia
Azad, M. C., Shoesmith, W. D., Mamun, M. A., Abdullah, A. F., Naing, D. K. S., Phanindranath, M., & Turin, T. C. (2015) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.11.012 · Cited by 77
Davis, L., Bogner, E., Coburn, N. G., Hanna, T. P., Kurdyak, P. A., Groome, P. A., & Mahar, A. L. (2019) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2019-212311 · Cited by 73
Ni, L., Wu, J., Long, Y., Tao, J., Xu, J., Yuan, X., Yu, N. H., Wu, R., & Zhang, Y. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2332-z · Cited by 70
Hendrie, H. C., Tu, W., Tabbey, R., Purnell, C. E., Ambuehl, R. J., & Callahan, C. M. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.025 · Cited by 68
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
Lee, J., Nam, D., & Lee, J. (2016) · Oncology Letters · doi:10.3892/ol.2016.4074 · Cited by 63
Inequalities in Lung Cancer Care of Elderly Patients With Schizophrenia
Bergamo, C. E., Sigel, K. M., Mhango, G., Kale, M., & Wisnivesky, J. P. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000050 · Cited by 60
Impact of socioeconomic deprivation on rate and cause of death in severe mental illness
Martin, J. L., McLean, G., Park, J. B., Martin, D. J., Connolly, M., Mercer, S. W., & Smıth, D. J. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0261-4 · Cited by 62
Female schizophrenia patients and risk of breast cancer: A population-based cohort study
Chou, A. I. W., Wang, Y.-C., Lin, C., & Kao, C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.019 · Cited by 56
Current state and future perspective of drug repurposing in malignant glioma
Siegelin, M. D., Schneider, E., Westhoff, M., Wirtz, C. R., & Karpel‐Massler, G. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.018 · Cited by 56
Schizophrenia and Cancer: In 2010 Do We Understand the Connection?
Bushe, C., & Hodgson, R. E. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005501203 · Cited by 55
Breast cancer in patients with schizophrenia
Farasatpour, M., Janardhan, R., Williams, C. D., Margenthaler, J. A., Virgo, K. S., & Johnson, F. E. (2013) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2012.06.013 · Cited by 53
Ishikawa, H., Yasunaga, H., Matsui, H., Fushimi, K., & Kawakami, N. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156265 · Cited by 53
Berchuck, J. E., Meyer, C. S., Zhang, N., Berchuck, C. M., Trivedi, N. N., Cohen, B. E., & Wang, S. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.1466 · Cited by 53
Do people with disabilities experience disparities in cancer care? A systematic review
Tosetti, I., & Kuper, H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285146 · Cited by 50
Cancer and mental health—a clinical and research unmet need
Purushotham, A. D., Bains, S., Lewison, G., SZMUKLER, G. I., & Sullivan, R. J. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt214 · Cited by 49
Evaluation of the Taking Texas Tobacco Free Workplace Program within behavioral health centers
Correa-Fernández, V., Wilson, W. T., Kyburz, B., O’Connor, D. P., Stacey, T., Williams, T., Lam, C. Y., & Reitzel, L. R. (2018) · Translational Behavioral Medicine · doi:10.1093/tbm/iby067 · Cited by 46
Predictors of Disruptions in Breast Cancer Care for Individuals with Schizophrenia
Irwin, K. E., Park, E. R., Shin, J. A., Fields, L. E., Jacobs, J. M., Greer, J. A., Taylor, J. B., Taghian, A. G., Freudenreich, O., Ryan, D. P., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0489 · Cited by 45
Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia
Morden, N. E., Lai, Z., Goodrich, D. E., MacKenzie, T., McCarthy, J. F., Austin, K., Welsh, D. E., Bartels, S., & Kilbourne, A. M. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.02.009 · Cited by 44
Reflections on access: too vulnerable to research?
Witham, G., Beddow, A., & Haigh, C. A. (2013) · Journal of research in nursing · doi:10.1177/1744987113499338 · Cited by 45
Mahar, A. L., Kurdyak, P. A., Hanna, T. P., Coburn, N. G., & Groome, P. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235409 · Cited by 45
Lin, C., Lane, H., Chen, T., Wu, Y., Wu, C., & Wu, V. Y. (2013) · Cancer Science · doi:10.1111/cas.12094 · Cited by 40
Lemogne, C., Nabi, H., Melchior, M., Goldberg, M., Limosin, F., Consoli, S., & Zins, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.015 · Cited by 37
Self-citationEllingrod, V. L., Taylor, S. F., Brook, R. D., Evans, S. J., Zöllner, S. K., Grove, T. B., Gardner, K. M., Bly, M. J., Pop‐Busui, R., & Dalack, G. W. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.031 · Cited by 40
Improving the physical health of people living with mental illness in Australia and New Zealand
Roberts, R. J., Lockett, H., Bagnall, C., Maylea, C., & Hopwood, M. (2018) · Australian Journal of Rural Health · doi:10.1111/ajr.12457 · Cited by 39
Gastrointestinal and liver disease in patients with schizophrenia: A narrative review
Grant, R. K., Brindle, W. M., Donnelly, M. C., McConville, P. M., Stroud, T. G., Bandieri, L., & Plevris, J. N. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i38.5515 · Cited by 39
Schizophrenia: Women Bear a Disproportionate Toll of Antipsychotic Side Effects
Seeman, M. V. (2010) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390309350918 · Cited by 37
Lin, J., McGlynn, K. A., Carter, C. A., Nations, J. A., Anderson, W. F., Shriver, C. D., & Zhu, K. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0316 · Cited by 40
Disparities in Oral Cancer Survival among Mentally Ill Patients
Chang, T., Hou, S.-J., Su, Y., Chen, L., Ho, H.-C., Lee, M., Lin, C.-H., Chou, P., & Lee, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070883 · Cited by 38
Høye, A., Jacobsen, B. K., & Hansen, V. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.021 · Cited by 37
Ng, C. G., Termorshuizen, F., Laan, W., Smeets, H. M., Zainal, N. Z., Kahn, R. S., de Wit, N. J., & Boks, M. P. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-012-0612-8 · Cited by 37
Identification of shared genetic variants between schizophrenia and lung cancer
Zuber, V., Jönsson, E. G., Frei, O., Witoelar, A., Thompson, W. K., Schork, A. J., Bettella, F., Wang, Y., Djurovic, S., Smeland, O. B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-16481-4 · Cited by 35
Dalton, S. O., Suppli, N. P., Ewertz, M., Kroman, N. T., Grassi, L. G., & Johansen, C. (2018) · The Breast · doi:10.1016/j.breast.2018.06.002 · Cited by 35
Mental Illness and Use of Screening Mammography Among Medicaid Beneficiaries
Koroukian, S. M., Bakaki, P. M., Golchin, N., Tyler, C. V., & Loue, S. (2012) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.03.002 · Cited by 35
Ribe, A. R., Laurberg, T., Laursen, T. M., Charles, M., Vedsted, P., & Vestergaard, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158013 · Cited by 35
Excess mortality in patients with schizophrenia spectrum disorders in Malaga (Spain): A cohort study
Moreno‐Küstner, B., Parra, J. G., Pardo, Y., Sanchidrián, Y., Díaz-Ruiz, S., & Mayoral, F. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796020001146 · Cited by 32
Leahy, D., Donnelly, A., Irwin, K. E., & D’Alton, P. (2021) · Psycho-Oncology · doi:10.1002/pon.5848 · Cited by 32
Weinstein, L. C., LaNoue, M. D., Hurley, K. E., Sifri, R., & Myers, R. E. (2015) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2015.0104 · Cited by 32
Kuo, P., Kao, C., Chen, P., Chen, C.-H., Tsai, Y.-S., Lu, M., & Huang, M. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318234ee84 · Cited by 29
Sikjær, M. G., Løkke, A., & Hilberg, O. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2017.12.012 · Cited by 29
Preventing breast cancer in women with schizophrenia
Seeman, M. V. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01626.x · Cited by 27
Rey, R., d’Amato, T., Boyer, L., Brunel, L., Aouizerate, B., Berna, F. S., Capdevielle, D., Chéreau, I., Chesnoy-Servanin, G., Denizot, H., et al. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0779-9 · Cited by 26
Lawrence, W. R., Gates, M. A., Hosler, A. S., Leinung, M. C., Zhang, X., Zhang, W., Du, Z., Schymura, M. J., & Boscoe, F. P. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113643 · Cited by 27
Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy
Grassi, L. G., Stivanello, E., Murri, M. B., Perlangeli, V., Pandolfi, P., Carnevali, F., Caruso, R., Saponaro, A., Ferri, M., Sanza, M., et al. (2021) · Psycho-Oncology · doi:10.1002/pon.5805 · Cited by 26
Adjuvant chemotherapy for breast cancer in patients with schizophrenia
Johnson, F. (2012) · Oncology Letters · doi:10.3892/ol.2012.560 · Cited by 28
Perini, G., Grigoletti, L., Hanife, B., Biggeri, A., Tansella, M., & Amaddeo, F. (2013) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-013-0765-0 · Cited by 26
Bernard, P., Romain, A. J., Esseul, E., Artigusse, M., Poy, Y., Baghdadli, A., & Ninot, G. (2013) · Science & Sports · doi:10.1016/j.scispo.2013.02.005 · Cited by 26
Burns, A., Strawbridge, J., Clancy, L., & Doyle, F. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.05.005 · Cited by 25
Yousefi, M. K., & Folsom, T. D. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s4-001 · Cited by 26
Caponnetto, P., Polosa, R., Robson, D., & Bauld, L. (2020) · Health Psychology Research · doi:10.4081/hpr.2020.9042 · Cited by 24
Palliative Care Psychiatry: Building Synergy Across the Spectrum
Shalev, D., Brenner, K. O., Carlson, R. L., Chammas, D., Levitt, S. E., Noufi, P. E., Robbins-Welty, G. A., & Webb, J. A. (2024) · Current Psychiatry Reports · doi:10.1007/s11920-024-01485-5 · Cited by 25
Kolli, V. B., Denton, K., Borra, D., Pulluri, M., & Sharma, A. (2012) · Psycho-Oncology · doi:10.1002/pon.3209 · Cited by 22
Increased risk of smoking-related illnesses in schizophrenia patients: A nationwide cohort study
Krieger, I., Bitan, D. T., Comaneshter, D. S., Cohen, A. D., & Feingold, D. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.058 · Cited by 22
Solmi, M., Croatto, G., Fabiano, N., Wong, S., Gupta, A. A., Fornaro, M., Schneider, L. K., Rohani-Montez, S. C., Fairley, L., Smith, N., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.11.001 · Cited by 22
Oxidatively generated DNA/RNA damage in psychological stress states.
Jørgensen, A. (2013) · PubMed · Cited by 20
Jacob, J. R., Palanichamy, K., & Chakravarti, A. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06779-3 · Cited by 22
Tada, Y., Matsubara, M., Kawada, S., Ishida, M., Wada, M., Wada, T., & Onishi, H. (2012) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyr200 · Cited by 20
Irwin, K. E., Steffens, E. B., Yoon, Y., Flores, E. J., Knight, H. P., Pirl, W. F., Freudenreich, O., Henderson, D. C., & Park, E. R. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201900044 · Cited by 20
Expanding Access to Cancer Clinical Trials for Patients With Mental Illness
Irwin, K. E., Moy, B., Fields, L. E., Callaway, C. A., Park, E. R., & Wirth, L. J. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01881 · Cited by 19
Arffman, M., Manderbacka, K., Suvisaari, J., Koivunen, J. P., Lumme, S., Keskimäki, I., Ahlgrén-Rimpiläinen, A., & Pukkala, . (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.06.018 · Cited by 18
Okoli, C. T. C., Otachi, J. K., Kaewbua, S., Woods, M. A., & Robertson, H. E. (2017) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390317704045 · Cited by 17
Diagnostic profile and suicide risk in schizophrenia spectrum disorder
Reutfors, J., Bahmanyar, S., Jönsson, E. G., Ekbom, A., Nordström, P., Brandt, L., & Ösby, U. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.014 · Cited by 16
Gordon, P. C., Louzã, M. R., & Xavier (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s37019 · Cited by 17
Continuation of Clozapine During Chemotherapy: A Case Report and Review of Literature
Cunningham, N. T., Dennis, N. M., Dattilo, W. R., Hunt, M. G., & Bradford, D. W. (2014) · Psychosomatics · doi:10.1016/j.psym.2014.05.007 · Cited by 14
Al-Nema, M. Y., Gaurav, A., & Akowuah, G. A. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.09.001 · Cited by 12
Weinstein, L. C., LaNoue, M., Hurley, K. E., Payton, C., Sifri, R., & Myers, R. E. (2019) · Journal of Primary Care & Community Health · doi:10.1177/2150132719867587 · Cited by 15
Adjuvant radiation therapy for breast cancer in patients with schizophrenia
Abdullah, K. N., Janardhan, R., Hwang, M. C., Williams, C. D., Farasatpour, M., Margenthaler, J. A., Virgo, K. S., & Johnson, F. E. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2014.07.004 · Cited by 14
Barriers and Facilitators to Breast Cancer Screening for Women With Severe Mental Illness
Linz, S. J., & Jerome-D’Emilia, B. (2022) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903221140600 · Cited by 13
Exercise Capacity and Quality of Life in Patients with Schizophrenia
Kerling, A., Tegtbur, U., Ziegenbein, M., Grams, L., Heinze, D. R., & Sieberer, M. G. (2013) · Psychiatric Quarterly · doi:10.1007/s11126-013-9256-4 · Cited by 13
Wang, Y., He, G., He, L., & McGrath, J. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.009 · Cited by 13
Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients
Li, Z., Zong, X., Li, D., He, Y. Z., Tang, J., Hu, M., & Chen, X. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04533-1 · Cited by 11
Safdieh, J. J., Schwartz, D. A., Rineer, J. M., Weiner, J., Wong, A. T., & Schreiber, D. P. (2015) · American Journal of Men s Health · doi:10.1177/1557988315610626 · Cited by 12
Metadata
- Authors
- Tran, E., Rouillon, F., Loze, J., Casadebaig, F., Philippe, A., Vitry, F., & Limosin, F.
- Affiliations
- Université de Reims Champagne-Ardenne (FR)
- Université Paris Cité (FR)
- Inserm (FR)
- ORCID
- Limosin, Frédéric
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2009-06-22
- Volume
- 115
- Issue
- 15
- Pages
- 3555-3562
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2021564981
- Cited by
- 173
- References
- 33
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 8 · 2023: 9 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 15 · 2018: 14 · 2017: 12 · 2016: 6 · 2015: 10 · 2014: 9 · 2013: 20 · 2012: 15
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Keywords
- schizophrenia, cancer mortality, premature mortality, lung cancer, breast cancer, sex differences, smoking duration, standardized mortality ratio, mortality risk factors
- MeSH terms
- Adolescent, Adult, Breast Neoplasms, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasms, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review